Zenas BioPharma (ZBIO) Shares Outstanding (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Shares Outstanding (Entity) of $62.4 million for Q1 2026, up 49.16% year-over-year from $41.8 million in Q1 2025, and up 39.47% quarter-over-quarter from $44.7 million in Q4 2025.
Zenas BioPharma (ZBIO) Shares Outstanding (2023 - 2026) Analysis & Trends
Zenas BioPharma's Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $62.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 49.16% year-over-year to $62.4 million; the TTM figure through Mar 2026 stood at $62.4 million (up 49.16% YoY), while the FY2025 annual figure was $44.7 million, up 238.89% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $62.4 million, up from $44.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $62.4 million in Q1 2026, with the low at $1.6 million in Q1 2024.
- The 4-year median for Shares Outstanding (Entity) is $13.2 million (2024), against an average of $23.7 million.
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) soared 2576.23% in 2025, then soared 49.16% in 2026.
- Zenas BioPharma's Shares Outstanding (Entity) stood at $1.6 million in 2023, then soared by 737.04% to $13.2 million in 2024, then soared by 238.89% to $44.7 million in 2025, then surged by 39.47% to $62.4 million in 2026.
- Business Quant data shows ZBIO's Shares Outstanding (Entity) at $62.4 million in Q1 2026, $44.7 million in Q4 2025, and $42.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | 63.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.11 Mn |
| Mar 31, 2026 | 55.62 Mn |
| Dec 31, 2025 | 44.73 Mn |
| Sep 30, 2025 | 42.16 Mn |
| Jun 30, 2025 | 41.87 Mn |
| Mar 31, 2025 | 41.80 Mn |
| Dec 31, 2024 | 13.20 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.54 Mn |